American Century Companies
QTTB icon

American Century Companies’s Q32 Bio QTTB Stock Holding History

American Century Companies’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121K Buy
+18,770
New +$89.2K ﹤0.01% 2765

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies's QTTB Position: Q1 2026 in Review

American Century Companies opened a new position in Q32 Bio (QTTB) in Q1 2026: 18,770 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #2765 among its holdings.

54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • American Century Companies held 18,770 shares of Q32 Bio worth $121K as of Q1 2026.
  • Q32 Bio was a new American Century Companies position in Q1 2026.
  • Q32 Bio made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2765 holding.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.